CRYO-CELL INTERNATIONAL, INC. Long-Term Debt, Maturity, after Year Five
CRYO-CELL INTERNATIONAL, INC. (CCEL) had Long-Term Debt, Maturity, after Year Five of $7.41 million as of 2025-11-30, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive · last filed 2026-02-27
- 2025-11-30: Long-Term Debt, Maturity, after Year Five $7.41M.
- 2024-11-30: Long-Term Debt, Maturity, after Year Five $7.63M.
| Period end | Long-Term Debt, Maturity, after Year Five |
|---|---|
| 2025-11-30 | $7.41M 10-K · filed 2026-02-27 |
| 2024-11-30 | $7.63M 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |